Two Sigma Investments, LP Tg Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$41.6 Billion
Q4 2024

A detailed history of Two Sigma Investments, LP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 606,208 shares of TGTX stock, worth $18.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

606,208

Previous 1,062,860 42.96%

Holding current value

$18.7 Million

Previous $24.9 Million 26.6%

% of portfolio

0.04%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$21.31 - $35.09 $9.73 Million - $16 Million	-456,652 Reduced 42.96%	606,208 $18.2 Million
Q3 2024 Nov 14, 2024	SELL	$17.21 - $25.28 $5.13 Million - $7.54 Million	-298,268 Reduced 21.91%	1,062,860 $24.9 Million
Q2 2024 Aug 14, 2024	BUY	$13.32 - $19.19 $14.6 Million - $21.1 Million	1,097,250 Added 415.82%	1,361,128 $24.2 Million
Q1 2024 May 15, 2024	BUY	$13.02 - $21.3 $1.42 Million - $2.32 Million	109,078 Added 70.46%	263,878 $4.01 Million
Q4 2023 Feb 14, 2024	SELL	$6.68 - $18.81 $14.6 Million - $41.1 Million	-2,186,554 Reduced 93.39%	154,800 $2.64 Million
Q3 2023 Nov 14, 2023	BUY	$8.36 - $26.5 $4.26 Million - $13.5 Million	508,972 Added 27.78%	2,341,354 $19.6 Million
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $7.42 Million - $16.8 Million	479,467 Added 35.44%	1,832,382 $45.5 Million
Q1 2023 May 15, 2023	BUY	$10.23 - $19.34 $3.48 Million - $6.57 Million	339,917 Added 33.56%	1,352,915 $20.3 Million
Q4 2022 Feb 14, 2023	SELL	$5.01 - $11.83 $769,355 - $1.82 Million	-153,564 Reduced 13.16%	1,012,998 $12 Million
Q3 2022 Nov 14, 2022	SELL	$4.57 - $8.4 $1.29 Million - $2.37 Million	-281,768 Reduced 19.45%	1,166,562 $6.91 Million
Q2 2022 Aug 15, 2022	BUY	$3.74 - $10.66 $2.33 Million - $6.64 Million	622,559 Added 75.39%	1,448,330 $6.16 Million
Q1 2022 May 16, 2022	BUY	$7.81 - $20.45 $6.45 Million - $16.9 Million	825,771 New	825,771 $7.85 Million
Q2 2021 Aug 16, 2021	SELL	$32.5 - $48.96 $3.85 Million - $5.8 Million	-118,438 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$41.61 - $54.3 $4.76 Million - $6.22 Million	-114,477 Reduced 49.15%	118,438 $5.71 Million
Q4 2020 Feb 16, 2021	BUY	$25.27 - $54.9 $5.89 Million - $12.8 Million	232,915 New	232,915 $12.1 Million
Q3 2020 Nov 16, 2020	SELL	$18.49 - $27.24 $4.22 Million - $6.22 Million	-228,191 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.9 - $21.84 $2.03 Million - $4.98 Million	228,191 New	228,191 $4.45 Million
Q1 2020 May 15, 2020	SELL	$7.14 - $15.99 $289,812 - $649,034	-40,590 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.1 - $11.2 $74,868 - $164,416	14,680 Added 56.66%	40,590 $451,000
Q3 2019 Nov 14, 2019	BUY	$5.38 - $8.99 $139,395 - $232,930	25,910 New	25,910 $145,000
Q1 2019 May 15, 2019	SELL	$4.02 - $8.04 $3.09 Million - $6.18 Million	-769,011 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.44 - $5.76 $2 Million - $3.36 Million	582,771 Added 312.91%	769,011 $3.15 Million
Q3 2018 Nov 14, 2018	BUY	$5.15 - $14.0 $959,136 - $2.61 Million	186,240 New	186,240 $1.04 Million

Others Institutions Holding TGTX

# of Institutions

371

Shares Held

85.5M

Call Options Held

3.78M

Put Options Held

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.49B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Tg Therapeutics, Inc. Transaction History